Genetic Testing to Identify Women at Risk of Venous Thromboembolism With Contraceptive Pills: Evidence or Hope-Based Tool ?

Swiss Medical Weekly - Switzerland
doi 10.4414/smw.2016.14321
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

EMH Swiss Medical Publishers, Ltd.

Related search

Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: A Systematic Review of Observational Studies

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Evidence for and Against Genetic Testing to Identify Children at Risk of High Myopia

Ophthalmology
Ophthalmology
2019English

Environmental and Genetic Risk Factors Associated With Venous Thromboembolism

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2016English

Safer Prescribing of Therapeutic Norethisterone for Women at Risk of Venous Thromboembolism

Journal of Family Planning and Reproductive Health Care
2012English

Lipid Profile of Women Using Oral Contraceptive Pills

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2012English

Evidence-Based Guidance on Venous Thromboembolism in Patients With Solid Tumours

Current Oncology
Oncology
2014English

Venous Thromboembolism an Observational Study to Assess the Risk of Venous Thromboembolism in Surgical Patients.

The Professional Medical Journal
2019English

Scores to Identify Occult Cancer in Venous Thromboembolism: Do They Work?

Thrombosis and Haemostasis
Hematology
2018English

Venous Thromboembolism Prophylaxis, or Lack of …

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy